HealthcareServices

Revenue of the Cholesterol Test Market Predicted to Achieve $15.25 Billion by 2030, Driven by 9% CAGR

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cholesterol test market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Cholesterol Test Market by the end of 2030?

The cholesterol test market size has experienced robust expansion in recent years. This market is projected to expand from $9.94 billion in 2025 to $10.8 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.7%. The historical growth trajectory is largely due to factors such as the increasing prevalence of cardiovascular diseases, heightened awareness of cholesterol monitoring, the expansion of diagnostic laboratory networks, an increase in preventive healthcare screening, and the availability of affordable test kits.

The cholesterol test market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $15.25 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.0%. This expansion during the forecast period is fueled by several factors, including a heightened demand for self-monitoring diagnostic tools, an increased emphasis on early disease detection, the broadening of remote patient testing solutions, the growing incorporation of digital health platforms, and the wider uptake of personalized healthcare diagnostics. Key trends expected during this period involve a greater acceptance of home-based cholesterol testing kits, a surge in the need for point-of-care lipid testing devices, the increasing utilization of multi-parameter lipid panels, an expansion of preventive cardiovascular screening initiatives, and a stronger emphasis on achieving rapid and accurate test outcomes.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11968&type=smp

What Drivers Are Shaping Future Opportunities In The Cholesterol Test Market?

The expanding occurrence of cardiovascular diseases is anticipated to boost the expansion of the cholesterol test market. Cardiovascular diseases, often abbreviated as CVDs, encompass a range of conditions affecting the heart and blood vessels, such as coronary heart disease, stroke, peripheral arterial disease, and aortic disease, among others. Cholesterol tests offer crucial data to individuals and medical professionals regarding the likelihood of developing heart disease. For example, the National Institutes of Health, a US-based government agency, reported in August 2025 that between 2025 and 2050, cardiovascular prevalence is projected to rise by 90%, mortality by 73%, and DALYs by 55%, with deaths increasing from 20.5 million to 35.6 million. Consequently, the growing number of deaths and the widespread presence of cardiovascular diseases are poised to fuel the cholesterol test market.

Which Segments Are Gaining Traction In The Cholesterol Test Market?

The cholesterol test market covered in this report is segmented –

1) By Product Type: Test Kits, Test Strips, Other Product Types

2) By Test Type: Total Cholesterol Test, High-Density Lipoprotein (HDL) Cholesterol, Low-Density Lipoprotein (LDL) Cholesterol, Triglycerides Or Very Low-Density Lipoprotein (VLDL) Cholesterol Test

3) By Distribution Channel: Over The Counter, Prescription Based

4) By End User: Hospitals, Diagnostic Centers, Other End-Users

Subsegments:

1) By Test Kits: Home Testing Kits, Laboratory Testing Kits

2) By Test Strips: Disposable Test Strips, Multi-Use Test Strips

3) By Other Product Types: Point-Of-Care Testing Devices, Cholesterol Monitors, Reagents And Calibration Solutions

What Upcoming Trends Are Likely To Define The Future Path Of The Cholesterol Test Market?

Leading firms within the cholesterol test market are concentrating on creating cutting-edge solutions, like blood testing systems, aimed at improving the early detection and ongoing monitoring of cholesterol, enhancing patient results, facilitating customized treatment plans, and bolstering preventive health efforts. Such a system represents a comprehensive platform designed for analyzing blood samples to identify various components, markers, or health conditions. As an example, Babson Diagnostics, Inc., an Australia-based healthcare technology startup, introduced its innovative BetterWay system in March 2024, which is a blood testing solution featuring the MiniDraw device for collecting samples from a fingertip. This system gently warms the patient’s hand, extracts a minimal, pea-sized blood sample using a lancet-equipped device, and automates its preparation, covering aspects like mixing and temperature control, prior to sending it to Babson’s laboratory for detailed analysis. The BetterWay system can assess cholesterol, blood cell counts, along with liver, kidney, and thyroid function using only a tiny amount of blood, providing results within one to two days, thereby enhancing patient comfort and convenience. This methodology effectively bridges the divide between conventional laboratory testing and accessible point-of-care solutions, significantly improving routine cholesterol monitoring.

Who Are The Core Companies Influencing Trends In The Cholesterol Test Market?

Major companies operating in the cholesterol test market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers GmbH, Fujifilm Holdings Corporation, CVS Health Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Mindray Medical International Limited, SYNLAB International GmbH, Beckman Coulter Inc., PerkinElmer Inc., Horiba Ltd., Sigma-Aldrich Corp, Randox Laboratories Ltd., Nova Biomedical Corp, Abcam plc, Sinocare Inc., ACM Global Laboratories, Clinical Reference Laboratory Inc., Sekisui Diagnostics LLC, Everlywell Inc., SpectraCell Laboratories Inc., LetsGetChecked USA, Ulta Lab Tests LLC, Cell Biolabs Inc., BioReference Health LLC, Diazyme Laboratories Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Cholesterol Test Market?

North America was the largest region in the cholesterol test market in 2025. The regions covered in the cholesterol test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cholesterol Test Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11968&type=smp

Browse Through More Reports Similar to the Global Cholesterol Test Market 2026, By The Business Research Company

Lipid Panel Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

Poc Cholesterol Test Market 2026

https://www.thebusinessresearchcompany.com/report/poc-cholesterol-test-market

Low Density Lipoprotein Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/low-density-lipoprotein-test-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795